Deltex Medical (DEMG)
market vs.
industry GROWTH & VALUE
| 12m Forecast Rolling | ||||
| PE Ratio (f) | n/a |
|
|
|
| PEG Ratio (f) |
|
|
||
| EPS Growth (f) | % |
|
|
|
| Dividend Yield (f) | % |
|
|
|
| Valuation (ttm) | ||||
| Price to Book Value | 13.8 |
|
|
|
| Price to Tang. Book |
|
|
||
| Price to Free Cashflow |
|
|
||
| Price to Sales |
|
|
||
| EV to EBITDA |
|
|
||
market vs.
industry QUALITY
| Year End 31st Dec | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013E | 2014E | CAGR / Avg | |
| Revenue | £m | |||||||||
| Operating Profit | £m | |||||||||
| Net Profit | £m | |||||||||
| EPS Reported | p | |||||||||
| EPS Normalised | p | |||||||||
| EPS Growth | % | |||||||||
| PE Ratio | x | |||||||||
| PEG | x | |||||||||
| Profitability | ||||||||||
| Operating Margin | % | |||||||||
| ROA | % | |||||||||
| ROCE | % | |||||||||
| ROE | % | |||||||||
| Cashflow | ||||||||||
| Op. Cashflow ps | p | |||||||||
| Capex ps | p | |||||||||
| Free Cashflow ps | p | |||||||||
| Dividends | ||||||||||
| Dividend ps | p | |||||||||
| Dividend Growth | % | |||||||||
| Dividend Yield | % | |||||||||
| Dividend Cover | x | |||||||||
| Balance Sheet | ||||||||||
| Cash etc | £m | |||||||||
| Working Capital | £m | |||||||||
| Net Fixed Assets | £m | |||||||||
| Net Debt | £m | |||||||||
| Book Value | £m | |||||||||
| Average Shares | m | |||||||||
| Book Value ps | p | -1.4% | ||||||||
FINANCIAL BRIEF: For the fiscal year ended 31 December 2012, Deltex Medical Group plc revenues increased 8% to L6.8M. Net loss increased 47% to L2.1M. Revenues reflect Probes segment increase of 10% to L5.3M, Other segment increase of 7% to L226K, United Kingdom segment increase of 9% to L4.1M, United States segment increase of 13% to L801K, International segment increase of 3% to L1.8M. more »
| Leverage (ttm) | Total | Ex Intang | |||
| Gross Gearing | % | ||||
| Net Gearing | % | ||||
| Cash / Assets | % | ||||
| Liquidity (ttm) | ||
| Current Ratio | ||
| Quick Ratio | ||
| Interest Cover | ||
| Efficiency (ttm) | ||
| Asset Turnover | ||
| Rec's Turnover | ||
| Stock Turnover | ||
market vs.
industry RECENT HISTORY
| Latest interim period (ended 31st Dec '12) vs. prior year | ||||
| Sales Growth | % |
|
|
|
| EPS Growth | % |
|
|
|
| 3yr Average Annualised | ||||
| Sales Growth | % |
|
|
|
| EPS Growth | % |
|
|
|
| DPS Growth | % |
|
|
|
BROKER CONSENSUS & FORECAST TREND
| Recommendation: | Strong Sell | Sell | Hold | Buy | Strong Buy |
|---|---|---|---|---|---|
| No. of Analysts: | 0 | 0 | 0 | 0 | 1 |
Deltex Medical Group plc is a holding company. The Company is engaged in the research, development, manufacture and sale of oesophageal Doppler haemodynamic monitoring systems (ODM). It has four segments: the UK segment, the USA segment, the Spanish segment and the International segment. Its CardioQ-ODM enables doctors to fine-tune a patient’s cardiac performance during surgery using a technique known as Doppler-guided fluid management. ODM is the technology to measure blood flows in the central circulation; it is sensitive to changes in flow. Its subsidiaries include Deltex Medical Limited, which manufactures and markets medical devices; Deltex Medical (Chichester) Limited, which provides employee services; Deltex Medical SC, Inc., which markets and sells medical devices in the United States, which are manufactured by the Company in the United Kingdom and Deltex Medical, Espana, which markets and sells medical devices in Spain, which are manufactured by it in the United Kingdom.
Directors: Nigel Keen (CEO) , Ewan Phillips (Fin. Dir.) ,
No. of Employees: 75 No. of Shareholders: n/a
| Last Annual | December 31st, 2012 |
| Last Interim | December 31st, 2012 |
| Shares in Issue | 164,383,628 |
| Free Float | 141.1m (85.8%) |
| Sector | Healthcare |
| Industry | Healthcare Equipment & Supplies |
| Index | FTSE Aim All Share, |
| Exchange |
London Stock Exchange (AIM) |
| Eligible for | an ISA? a SIPP? |
| Address | , Chichester, PO19 8TX, United Kingdom |
| Web | http://www.deltexmedical.com/ |
| Phone | +44 1243 774837 |
| Contact | Ewan Phillips (Fin. Dir.) |
| Registrar | Registeries Limited |
| Auditors | PricewaterhouseCoopers LLP |
| 30th May | Clinical Guidelines for Anaesthetists in France |
| 17th May | Director/PDMR Shareholding |
| 1st May | Result of AGM |
| 30th Apr | AGM Statement |
| 24th Apr | Holding(s) in Company |
| 23rd Apr | Holding(s) in Company |
Recent ↓
